Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6923 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6929 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-547 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409 |
filingDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101863667-B1 |
titleOfInvention |
Treatment of retinitis pigmentosa using hyaluronic acid-carbon nano material-photosensitizer complex |
abstract |
The present invention relates to hyaluronic acid or derivatives thereof; A carbon nanomaterial that is covalently linked to the hyaluronic acid or derivative thereof; And a photosensitizer combined with the carbon nanomaterial. The present invention also provides a combination for improving or treating a retinal disease. The conjugate for improving or treating retinal disease of the present invention can selectively inhibit active oxygen production in retinal epithelial cells for a relatively long period of time by using the hyaluronic acid-carbon nanomaterial-photosensitizer conjugate, And intracellular penetration can be facilitated. Further, it is possible to provide a composition for improving or treating a retinal disease comprising the hyaluronic acid-carbon nanomaterial-photosensitizer conjugate. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102168332-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102025041-B1 |
priorityDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |